9th Jun 2016 07:33
LONDON (Alliance News) - Deltex Medical Group PLC on Thursday said it has secured two new accounts for its US platform programme.
Deltex, which manufacturers oesophageal Doppler monitoring probes, said the first account is with an unnamed major hospital in the San Francisco Bay area. The hospital, the sixth West Coast account secured by Deltex, has placed an initial order for 50 probes and is contracted to buy another 30 per month going forward.
The second account comprises a collection of hospitals in the north east of the US. The hospitals are collaborating on introducing enhanced recovery protocols in bowel surgery, Deltex said.
The new wins bring the number of US platform accounts for Deltex up to 24.
"Adoption rates in the USA, our key territory for development, continue to outperform our other areas of focus. Additional platform accounts contribute to recurring sales growth in the USA, where probe revenues in the five months to the end of May are over 50% ahead of the corresponding period in 2015," said Chief Executive Ewan Phillips.
Deltex shares were up 13% to 4.96 pence early Thursday, one of the best performers in the AIM All-Share.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Deltex Medical